REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 36.76B KRW in the quarter ending March 31, 2025, a decrease of -0.69%. This brings the company's revenue in the last twelve months to 148.04B, down -1.99% year-over-year. In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B, down -1.83%.

Revenue (ttm)

148.04B

Revenue Growth

-1.99%

P/S Ratio

1.36

Revenue / Employee

330.45M

Employees

448

Market Cap

201.20B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2012	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
LigaChem Biosciences	146.42B

Revenue Rankings